Here, we find that IL-4/IL-13 polarized M2a macrophages enhance breast cancer cell migration and invasion at a greater rate than either M2b or M2c macrophages and are thus an important subpopulation to target therapeutically. The gene discussed is IL4; the disease is breast cancer.